The general anesthetic ketamine (Ketalar | Ketaject, Vetalar) (KET) is used in human and veterinary medicine for induction of anesthesia for short surgical procedures and routine veterinary examination. Its illicit use by teenagers in rave parties has been reported, and it has recently been identified as a substance associated with sexual assault. One aim of this paper was to study the elimination of KET and its major metabolite norketamine (NKET) in urine collected from five nonhuman primates that received a single dose (5 mg/kg, I.M.) of KET and to study elimination patterns to determine how long after drug administration KET and NKET can be detected. Another aim of this study was to develop and validate a highly sensitive negative ion chemical ionization-gas chromatography-mass spectrometry (NCI-GC-MS) method for the simultaneous quantitation of KET and its major metabolite NKET in urine and to analyze urine samples collected from the animals. The last aim of this study was to apply and evaluate a newly developed ELISA screening methodology for detection of KET and its metabolites in the same urine samples collected from primates which received a single dose of KET. In two monkeys, KET was detected in urine up to 3 days after drug administration (32-7070 ng/mL); in one monkey, it was detected up to 4 days (65-13,500 ng/mL); in one monkey, it was detected only on days 1 and 2 (4000 and 70 ng/mL, respectively); and in one monkey, it was detected 10 days after KET injection (22-35,000 ng/mL). NKET concentrations ranged from 63 pg/mL to 1.75 pg/mL, and it remained in the urine throughout the entire 35-day study period in 4 out of 5 animals. In one monkey, NKET was detected up to 31 days after KET administration. Urine analysis using ELISA revealed that KET and NKET can be easily detectable at 25 ng/mL. In one monkey, KET and its metabolites were detected in urine up to 4 days after drug administration, up to 7 days in two monkeys, up to 11 days in one monkey, and 16 days after KET injection in one monkey. Urine extraction followed by screening using ELISA methodology allowed for significant extension of the detection period in all animals from the study. It is believed that the KET elimination in urine of nonhuman primates is slightly faster than in humans. We propose that NCI-GC-MS be employed to detect NKET as a target compound in urine in toxicological investigations of drug-facilitated sexual assault when KET use by the perpetrator is suspected.
Introduction
Ketamine (Ketalar, Ketaject, Vetalar) (KET) was introduced to the market in the 1960s as a unique anesthetic agent. It is structurally related to phencyclidine (PCP), but it has only 25% of the psychotomimetic activity of PCP. The pharmacology of KET is complex. Like PCP, KET has activity at multiple sites in the brain (1) . KET primarily acts as a glutamate antagonist by noncompetitively binding to the PCP receptor located in the ion channel of the N-methyl d-aspartate (NMDA) receptor complex. It sterically blocks the cation channel gated by the NMDA receptor, impeding the flow of Na § and Ca 2 § ions into the neuron and resulting in disruption of glutamate-mediated transmission at these sites throughout the brain. The (S)-isomer is more potent in displacing the NMDA ligand from its receptor than (R)-KET (2) . In addition, KET facilitates monoamine transmission by inhibiting the reuptake of dopamine, norepinephrine, and serotonin, resulting in an accumulation of these neurotransmitters in synapses. KET also acts on the opiate system as an agonist at the p-opiate receptor. When abused, KET can produce psychotic symptoms and cognitive impairment that may persist for up to three days (3) . Clinically, KET has been used to induce schizophrenia as a model of psychosis (4) . Like PCP, KET induces short-lived psychotic symptoms in non-schizophrenic volunteers. Many investigators believe KET psychosis to be superior to amphetamine psychosis in mimicking the negative symptoms of schizophrenia.
KET is rapidly metabolized with the principal metabolites being an active metabolite, norketamine (NKET), and an inactive metabolite, 6-hydroxynorketamine (5) . KET is demethylated to NKET by the liver microsomal cytochrome P450 system. Hijazi et al. (6) have demonstrated that, in human liver microsomes, the isoforms CYP3A4, CYP2B6, and CYP2C9 all play a role in the biotransformation of KET to NKET. However, they have convincingly argued that the low affinity/high capacity enzyme, CYP3A4, is primarily responsible for heptatic N-demethylation of KET at therapeutic doses. When KET is given intramuscularly (I.M.) to human subjects, its plasma levels exceed NKET over the first hour, and then they are similar thereafter (7) . However, oral administration of KET produces much higher plasma levels of NKET in humans (7) and rats (8) because of extensive first-pass metabolism. KET is regulated as a Schedule III controlled substance.
Recently, there has been a resurgence of interest in KET due to its appearing as a "club drug" at rave parties and at bars. On the streets, it is known as "K", "Special K", and "Cat Valium" as well as many other names. The primary source for KET is diversion from veterinary clinics where it is available as a parenteral solution (9) . KET is used in a liquid form, its pharmaceutical preparation, or as a powder formed by allowing the solvent of the injectable to evaporate. It is taken voluntarily by intramuscular injection, intranasally, or orally. KET can be ingested involuntarily when it is unknowingly added to a drink to induce a stupor for drug-facilitated sexual assault, that is, a "date-rape" drug (10, 11) . Although it is not used as frequently as other drugs such as Ecstasy (MDMA), KET abuse by club drug users is increasing (9) . A recent NIDA-funded study conducted by the University of Illinois at Chicago showed that the prevalence of KET use in a population of men having sex with men exceeded 10% (Fendrich et al., manuscript in preparation). When used in subanesthetic doses, KET induces euphoria and sedation. Its analgesia may be beneficial in reducing the muscular pain associated with fatigue caused by prolonged physical activity such as dancing. KET functions as a date-rape drug by producing sedation, stupor, and memory impairment, rendering the victim defenseless in thwarting off the offender and helpless in recalling the details of the incident (10) .
In this context, the aim of this study was to develop and validate a highly sensitive negative ion chemical ionization-gas chromatography-mass spectrometry (NCI-GC-MS) method for the simultaneous quantitation of KET and its major metabolite NKET in urine. The developed methodology was applied to analyze urine samples collected from nonhuman primates that received a single dose of KET for NKET and KET in order to determine how long after administration of the drug the parent compound and metabolite can be detected. The data are of great importance to law enforcement agencies and the forensic toxicology community in order to determine how long after sexual assault the urine samples can be collected from the victim to reveal the drug use and to successfully prosecute the perpetrator. The other objective of this study was to apply and evaluate a newly developed ELISA screening methodology for detection of KET and NKET in urine samples collected from the same animals and to explore the possibility of increasing detectibility by extracting urine samples prior to ELISA screening.
Experimental

Animals
Urine was collected from five stumptail macaques (Macaca arctoides), four females (8-19 kg) and one male (17 kg), caged individually. All animals received a wash-out period of six months prior to the experiment. One urine sample was collected from each animal before KET administration. All monkeys received a single dose (5 mg/kg, I.M.) of KET. This dose represents an average I.M. dose in humans (3-8 mg/kg). Urine samples were collected from each animal every 18 h (excluding weekends) for up to 24 days then once every 4 days up to 35 days. The study protocol was reviewed and approved by the University of Illinois at Chicago Animal Care Committee. Chemicals and reagents. KET (1 mg/mL), NKET (1 mg/mL), and the internal standard NKET-d4 (100 mg/mL) were purchased from Cerilliant Corporation (Round Rock, TX). Urine standards and controls. A standard curve was prepared by spiking negative urine with known quantities of KET, NKET, and NKET-d4. Five-point standard curves for KET and NKET were prepared by spiking aliquots (2 mL) of negative urine. The final concentrations of KET were 0, 20, 50, 100, 500, and 1000 ng/mL and NKET were 0, 50, 200, 500, 1000, 1500, and 5000 pg/mL. In addition, two levels of control urine preparations were analyzed (100 pg/mL and 1200 pg/mL for NKET, and 40 ng/mL and 750 ng/mL for KET).
GC-MS
Instrumentation
Analyticalprocedure. The frozen urine samples were thawed at room temperature. To all standard, control, and study samples, internal standard (NKET-d4 1000 pg/mL), 0.1M acetate buffer (pH 4.5, I mL), and crude ~-glucuronidase solution (50 IJL, Type H-2, 110,350 units/mL, Helix pomatia) were added, and samples were incubated for 1.5 h at 37~ After incubation, 1.93M acetic acid (1 mL) and deionized water (10 mL) were added. Each SPE column was conditioned with methanol (3 mL), deionized water (3 mL), and 1.93M acetic acid (1 mL); the sample was then added and the column was washed with deionized water (3 mL), 0.1N HC1 (1 mL), and methanol (3 mL). The final elution from the extraction column was achieved using methylene chloride/isopropanol/ammonia (78:20:2, v/v/v, 3 mL). All extracts were evaporated to dryness with nitrogen, dissolved in ethyl acetate (50 I~L), and transferred to autosampier vials. Dried samples were derivatized (30 rain, 60~ using HFBA (50 IJL). HFBA was evaporated under vacuum at 60~ and the dry residue was dissolved in ethyl acetate (30 IJL).
Concentrations of KET and NKET found in many urine samples were outside the linear range as established by the standard curve. Those samples were diluted with deionized water and reextracted in the same manner as before. The dilutions made were recorded and used to calculate the initial concentration of both compounds in the sample.
Quantitation of KET and NKET was performed by the internal standard method. Five-point standard curves were prepared by linear least-squares regression analysis of the ratio of the peak area of KET and NKET to the peak area of the internal standard, NKET-d4. Peak-area ratios were determined for the controls. Control concentrations were calculated from the standard curve values. All data were acquired and analyzed by HP software, Enhanced G1701BA ChemStation version B.00.00 for Windows NT.
NCI-GC-MS analysis
A Hewlett-Packard GC-MS instrument (6890 GC and 5973 MSD) operating in chemical ionization mode was used for the analysis. The column was an HP5-MS (30-m length • 0.2-1~m i.d., 0.25-1Jm film thickness), and the collision gas was methane maintained at an ion gauge pressure of 3.8 • 10 -4 Torr. The injector temperature was 240~ the transfer line was 280~ and the source and quadrupole were kept at 200~ and 106~ respectively. The oven was held at 60~ for I rain then ramped at 30~
to a final temperature of 310~ where it was held for 3 rain. The injection volume was 1 IJL. The monitored ions were m/z 226 and 357 for KET derivative, m/z 383 and 399 for NKET, and m/z 387 and 403 for NKET-d4.
ELISA analysis
Materials. Micro-plate reader and KET ELISA kits were kindly provided by Neogen Corporation (Lexington, KY). All reagents and materials used for solid-phase extraction (SPE) were the same as previously described.
Screening of urine for KET. The kit was first tested using urine spiked with KET or NKET at the following concentrations: 0, 5, 10, 25, 50, 75, 100, 500, 1000, 1500, and 2000 ng/mL. They were tested using the following procedure. Twenty microliters of sample or control (positive or negative) was added to the appropriate well. One hundred and eighty microliters of a 1:180 dilution of enzyme conjugate in Neogen's EIA buffer was then added to each well. The plate was then covered with parafilm and incubated at room temperature for 45 min. Each well was then washed three times with 300 laL of Neogen's wash buffer, and 150 IlL of Neogen's K-Blue Substrate was added to each well and incubated at room temperature for 30 min. The plate was gently shaken periodically throughout the incubation. To ensure uniform color development, 50 IJL of Neogen's red stop solution was added to each well in order to stop the reaction. The plate was read at 650 nm.
After the limitations of the kit and cross-reactivity with NKET was established, urine samples collected from monkeys dosed with KET over 39 days were tested.
SPE. All urine samples were hydrolyzed with [B-glucuronidase and extracted using mixed-mode SPE columns (200 rag, 10 mL, Isolute HCX) as previously described. After final elution with methylene chloride/isopropanol/ammonium hydroxide (78:20:2, v/v; 3 mL), the eluent was evaporated to dryness and the residues were reconstituted in Neogen's buffer (20 mL). The solutions were transferred to microplate wells and the described analytical procedure was followed.
Results
The retention time of KET and NKET (NKET-d4) was approximately 7.95 and 7.41 min, respectively. The chromatograms were recorded over the time range from 6 to 9 min. The standard curves had correlation coefficients of 1.000 for KET and 0.993 for NKET. The limits of detection (LOD) for KET and NKET was 5 ng/mL and 5 pg/mL, respectively, which were the lowest concentrations of drugs at which the signal-tonoise ratio was 3:1. The limits of quantitation (LOQ) for KET and NKET were 20 ng/mL and 50 pg/mL, respectively, arbitrarily set as the lowest point on the standard curve. Figure 1 shows elimination of KET in urine after a single dose of the drug. In two monkeys, KET was detected up to three days after drug administration (32-7070 ng/mL). In one monkey, it was detected up to four days (65-13,500 ng/mL), and in another monkey, it was detected only on days 1 and 2 (4000 and 70 ng/mL, respectively). In one animal, it was detected 10 days after KET injection (35,000-22 ng/mL). Elimination of NKET in urine of five animals used in the study is presented in Figure  2 . NKET concentrations in urine ranged from 63 pg/mL to 1.75 lJg/mL, and it remained in urine throughout the entire 35-day study period in 4 out of 5 animals. In one monkey, NKET was detected up to 31 days after KET administration.
Urine analysis using ELISA revealed that KET and NKET can be easily detectable at 25 ng/mL. In one monkey, KET and its metabolite were detected in urine up to four days after drug administration, and in two, it was detectable up to seven days. In another, it was detectable up to 11 days, and in one animal, it was detectable 16 days after KET injection. Figure 3 presents a comparison of KET detection interval before and after SPE from urine. As expected, urine extraction after enzymatic hydrolysis followed by screening using ELISA methodology allowed a significant extension of the drug detection period in the study, possibly due to a cross-reactivity with other metabolites. Figure 4 shows a comparison between detection intervals for NCI-GC-MS and ELISA. In one animal, KET and metabolites were detected by both techniques throughout the entire 35-day study period.
Discussion
During the last decade an increase in the number of reports of drug-facilitated sexual assault (DFSA) has been observed (11) . All drugs used in DFSA have depressant effects on their users. Symptoms reported by victims of alleged drug-facilitated rape include confusion, decreased heart rate, dizziness, drowsiness, impaired judgment, impaired memory, lack of muscle control, loss of consciousness, nausea, reduced blood pressure, and reduced inhibition. All these effects can be synergistically enhanced if the drug is taken with alcohol. Incidents of this type have prompted federal legislation known as the "Drug-Induced Rape Prevention & Punishment Act of 1996" increasing a penalty for the person who commits this crime up to 20 years in prison. Recently, the Society of Forensic Toxicologists (SOFT) created a Sexual Assault Committee designed to tackle the issue of DFSA in the Toxicology field. This committee prepared a list of drugs that could be, or have been, used in drug-facilitated sexual assault. During the last few years, KET has been shown as a drug of quickly increasing popularity in bars, disco-dancing, and rave parties (12) (13) (14) (15) (16) and has been added to the list of socalled "club drugs" and drugs associated with sexual assault. Moore et al. (12) Figure 3 . Number of days NKET can be detected using ELISA before and after extraction. time with flunitrazepam by Negrusz et al. (17) . A similar study with a single dose of clonazepam was recently published by the same group (18) . This paper presents an elimination of KET and its major metabolite NKET in urine after a single dose of the drug using an animal model with nonhuman primates. As shown, the parent KET can only be detected a few days after drug administration (up to four days in one animal only). In a case of one monkey, the elimination of KET was extended to 10 days post-dose, and the initial concentration of KET in urine was the highest (35,000 ng/mL). NKET concentrations in urine were usually lower than those of KET and ranged from 63 pg/mL to 1.75 IJg/mL. Unlike KET, NKET remained in urine throughout the entire 35-day study period in 4 out of 5 animals. In one monkey, NKET was detected up to 31 days after KET administration. The NCI-GC-MS method described in this study allowed an LOQ for KET derivatized with HFBA to be 20 ng/mL, much higher than for NKET (50 pg/mL). The difference in sensitivity between both compounds after derivatization with HBFA is due to much better efficiency of acylation for NKET than parent KET and, consequently, an increased detectability by the MSD operating in a negative ion chemical ionization mode. Moore et al. (12) described a liquid chromatography-mass spectrometry methodology for KET, NKET, and dehydronorketamine (DNKET) with an LOD of 4 ng/mL for KET and NKET. The concentrations of NKET in 33 positive urine samples collected from drug users were usually higher than KET. Confirmation of all samples for KET was done using full-scan GC-MS with the lowest calibrator concentration 10 ng/mL and extraction from 5 mL of urine. Very recently Chou et al. (15) applied both EI-GC-MS and PCI-GC-MS for detection of KET and NKET in urine after liquid-liquid extraction and derivatization with pentafluorobenzoyl chloride. In their study, EI-GC-MS provided much better LOQs for KET and NKET (13 and 9 ng/mL, respectively) than PCI-GC-MS. In another paper by Olmos-Carona et al. (16) , the LOD for KET in urine was 5 ng/mL. The increasing abuse of KET during the last few years has led many urine drug testing laboratories to consider adding KET screening to their programs (12, 15) . Not that long ago, the Neogen Corporation developed the first microplate enzymelinked immunosorbent assay (ELISA) for KET in urine. The kits generously donated to us by Neogen Corporation were tested using urine samples collected from monkeys that received a single dose of KET. It is our conclusion that the ELISA test is sensitive enough to reveal KET use several days following administration. The detection interval can be substantially increased if SPE followed by ELISA screening is performed.
Finally, using ELISA screening and NCI-GC-MS, it is possible to significantly extend the window of detection for KET and its major metabolite. A larger window of detection could dramatically improve the ability of forensic toxicology laboratories to detect drugs used in DFSA cases, which could increase the success with which these difficult cases are prosecuted. An improvement of the conviction rate might encourage more victims to report these assaults while discouraging potential rapists from committing these crimes. We propose that NCI-GC-MS be employed to detect NKET as a target compound in urine in toxicological investigation of drug-facilitated sexual assault when KET use by the perpetrator is suspected.
Conclusions
The NCI-GC-MS methodology presented in this paper for determination of KET and NKET levels in urine is simple, very sensitive, specific, and relatively inexpensive. After a single dose of KET, NKET remains in urine of nonhuman primates for extended periods of time. The newly developed ELISA screening procedure for KET and its metabolite is sensitive, simple, inexpensive, and can detect these substances several days after administration of a single dose. The detection interval can be significantly extended if SPE is employed prior to ELISA screening.
